Products
Investing
Resources
Support
Eris Lifesciences Limited (ERIS)
₹1,432.1
INR-42.10(-2.86%)
As of April 30, 2025 9:59:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹20915.24 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹22863.09 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
61.57
Forward P/E
Price to Earnings ratio based on forecasted earnings
35.82
PEG Ratio
Price/Earnings to Growth ratio
35.82
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
7.68
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
75.51%
Operating Margin
Operating income as a percentage of revenue
23.42%
Return on Equity
Net income as a percentage of shareholders' equity
12.17%
Revenue (TTM)
Total revenue over trailing 12 months
₹2723.92 Cr+49.4%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹938.80 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹24.23-18.6%
Balance Sheet
Total Cash
Total cash and short-term investments
₹242.55 Cr
Total Debt
Total short-term and long-term debt
₹2734.83 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
86.08%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹815.85 - ₹1593.9
Beta
Measure of stock's volatility compared to the market
0.12
Shares Outstanding
Total number of shares issued by the company
₹13.60 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
1.00%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
NA
Payout Ratio
Percentage of earnings paid as dividends
NA